Table of Contents
The Use of Parenteral Nalbuphine (Nubain) to Treat Adults with Sickle Pain Episodes
Treatment of Pain Episodes
Agonist - Antagonist Analgesic Agents
Nalbuphine HCL (Nubain - DuPont Pharmaceuticals)
The Comprehensive Sickle Cell Center at Grady
Study Design
Analgesics Used in 11,088 Pain Episodes in 537 Adults
Pain Relief Results of 2,681 Nubain Treated Episodes
Need for admission in 7,076 pain Episodes treated with Nubain
Safety Profile
Conclusions
|
Author: Allan Platt
Email: aplatt@emory.edu
Home Page: http://www.emory.edu/PEDS/SICKLE
Download presentation source
|